MedTrace Logo

The Endocrine Impact of the Duodenal-jejunal Bypass Sleeve on Type 2 Diabetes - Potential Role of the Incretin Hormones

NCT02360878 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2017-08-10

No results posted yet for this study

Summary

We want to evaluate the impact of the EndoBarrier Gastrointestinal Liner (DJBS) on glucose metabolism as well as gut and pancreatic hormone secretion.

Conditions

Interventions

DEVICE

EndoBarrier Gastrointestinal Liner

Implantation with the EndoBarrier

Sponsors & Collaborators

  • University of Copenhagen

    collaborator OTHER

  • Filip Krag Knop

    lead OTHER

Principal Investigators

  • Filip K Knop, MD, Ph.D. · Center for Diabetes Research, Gentofte Hospital, University of Copenhagen

  • Ulrich Rohde, MD · Center for Diabetes Research, Gentofte Hospital, University of Copenhagen

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2017-06-30
Completion
2017-07-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02360878 on ClinicalTrials.gov